Estudios originales
Published on 17 de junio de 2024 | http://doi.org/10.5867/medwave.2024.05.2781
Efficiency and comparability of using new evidence platforms for updating recommendations: Experience with a type-2 diabetes guideline in Colombia
Back to article
Agreement statistic for finding the 71 eligible references across the 10 possible pairs of search approaches.
| +/- (% Obs-Exp) | 8/31 (55 to 55) | 10/24 (48 to 52) | 9/25 (48 to 53) | 9/29 (54 to 54) | |
| Kappa (95% CI) | 0.01 (-0.22 to 0.23) | -0.08 (-0.32 to 0.15) | -0.10 (-0.33 to 0.13) | 0.00 (-0.23 to 0.23) | |
| +/- (% Obs-Exp) | 8/30 (54 to 54) | 7/31 (54 to 55) | 12/40 (73 to 58) | ||
| Kappa (95% CI) | -0.01 (-0.23 to 0.21) | -0.04 (-0.27 to 0.19) | 0.37 (0.14 to 0.60) | ||
| +/- (% Obs-Exp) | 10/25 (49 to 52) | 9/28 (52 to 53) | |||
| Kappa (95% CI) | -0.06 (-0.29 to 0.17) | -0.02 (-0.25 to 0.21) | |||
| +/- (% Obs-Exp) | 4/25 (41 to 54) | ||||
| Kappa (95% CI) | -0.29 (-0.52 to -0.06) |
+/-, positive/negative agreement (found/not found in both search approaches). Obs-Exp, Observed-Expected (by chance) agreement. CI, Confidence interval.